Skip to main content

Advertisement

Contact Shi-Ting Feng

From: Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Contact corresponding author